This is a list of androgens/anabolic steroids (AAS) or testosterone derivatives. Esters are mostly not included in this list; for esters, see here instead. The major classes of testosterone derivatives include the following (as well as combinations thereof):
- Testosterone derivatives: immediate derivatives of testosterone not falling into the groups below
- 4,5α-Reduced/dihydrogenated testosterone derivatives: dihydrotestosterone (DHT) derivatives
- 19-Demethylated testosterone derivatives: 19-nortestosterone (nandrolone) derivatives
- 17α-Alkylated testosterone derivatives: methyltestosterone and ethyltestosterone derivatives
- 17α-Ethenylated/ethynylated testosterone derivatives: ethynyltestosterone (ethisterone) and vinyltestosterone derivatives
The last group consists of progestins with mostly only very weak androgenic/anabolic activity.
AAS that are listed as marketed may be marketed as one or more esters rather than as the listed AAS itself.
This list specifically pertains to steroidal androgens; nonsteroidal androgens like the selective androgen receptor modulators (SARMs) andarine and enobosarm (ostarine) are not included here.
Natural/endogenous
edit- Marketed
- Androstenediol (A5; 5-androstenediol)
- Boldenone (δ1-T)*
- Dehydroepiandrosterone (DHEA; prasterone, 5-androstenolone)
- Dihydrotestosterone (DHT; androstanolone, stanolone)
- Nandrolone (19-NT; 19-nortestosterone)*
- Testosterone (T; 4-androstenolone)
- Never marketed
- 11-Ketodihydrotestosterone (11-KDHT)
- 11-Ketotestosterone (11-KT)
- 11β-Hydroxyandrostenedione (11β-OHA4)
- 19-Nor-5-androstenediol (19-NA5)*
- Adrenosterone (11-ketoandrostenedione; 11-KA4)
- Androstenedione (A4; 4-androstenedione)
- Androsterone
- Bolandione (19-nor-4-androstenedione)*
- Dehydroandrosterone (DHA; 5-dehydroandrosterone)
- Epiandrosterone
* Only present endogenously in trace/very small amounts or present in other species.
Synthetic
editTestosterone derivatives
edit
|
|
Dihydrotestosterone derivatives
edit
|
|
19-Nortestosterone derivatives
edit
|
|
Other testosterone derivatives
edit
|
|
See also
editReferences
editFurther reading
edit- Kicman, A T (2008). "Pharmacology of anabolic steroids". British Journal of Pharmacology. 154 (3): 502–521. doi:10.1038/bjp.2008.165. ISSN 0007-1188. PMC 2439524. PMID 18500378.
- Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C (2009). "Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure". Steroids. 74 (2): 172–97. doi:10.1016/j.steroids.2008.10.016. PMID 19028512. S2CID 41356223.
- McRobb L, Handelsman DJ, Kazlauskas R, Wilkinson S, McLeod MD, Heather AK (2008). "Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay". J. Steroid Biochem. Mol. Biol. 110 (1–2): 39–47. doi:10.1016/j.jsbmb.2007.10.008. PMID 18395441. S2CID 5612000.